About Us

Lerner Research Institute is home to laboratory-based, translational and clinical research at Cleveland Clinic, a top hospital in the nation. As a research institute embedded within an international hospital system, we are uniquely poised to improve patient care; our scientists work closely with Cleveland Clinic physicians to transform groundbreaking discoveries made in the laboratory to the patient’s bedside.

Since Cleveland Clinic’s founding in 1921, research and education have been integral parts of the hospital’s mission. The founders believed it was not only important to treat patients, but also to investigate the causes of disease.

Nearly 100 years later, Lerner Research Institute is at the forefront of discovery, with our scientists working to uncover novel biological pathways and develop new medical devices, diagnostics and therapies for cancer, cardiovascular and metabolic diseases, brain and eye diseases, and diseases of the inflammation and immune systems. As the field of biomedical research has evolved—with advances unimaginable even 10 or 20 years ago—so has research at Cleveland Clinic.

We are growing with and for the future of research. Our state-of-the-art biorepository offers streamlined patient consent processes, centralized storage and analytic capabilities for biological specimens to advance disease-specific, precision-based research. The Center for Therapeutics Discovery, which operates like a small pharmaceutical company, has a robust pipeline of innovative projects spanning many disease areas and supports projects all the way from target identification to licensing.

In addition to conducting leading-edge research, Lerner Research Institute is also committed to training the next generation of young scientists, offering joint programs with nearby universities, our own Molecular Medicine PhD program and a robust postdoctoral program.

190

Labs

1500+

Employees

250+

Postdoctoral Fellows

109

Graduate Students

$307M

Total Research Funding
(2019)

6,089

High-Impact Publications
(2014-2018)

92

Issued Patents
(2019)

Our Leadership

Serpil C. Erzurum, MD

Serpil C. Erzurum, MD

Chair, Lerner Research Institute

Thomas A. Hamilton, PhD

Thomas A. Hamilton, PhD

Vice Chair, Lerner Research Institute

Donna M.  Driscoll, PhD

Donna M. Driscoll, PhD

Director, Faculty Center

Christine Moravec, PhD

Christine Moravec, PhD

Director, Research Education and Training Center

Charlotte Bhasin, MOT, OTR/L

Charlotte Bhasin, MOT, OTR/L

Executive Director, Health and Patient-Focused Research

James D. Ellis, JD, MBA

James D. Ellis, JD, MBA

Executive Director, Strategic Alliances and Technology Development

Heather Huston Barkley, MBA

Heather Huston Barkley, MBA

Executive Director of Development

Mary Ann Verbic, MT (ASCP) SI

Mary Ann Verbic, MT (ASCP) SI

Executive Director, Exploratory Biomedical Sciences

Shannon Barnes, MS

Shannon Barnes, MS

Communications Director

Our Leadership

Serpil C. Erzurum, MD
Thomas A. Hamilton, PhD
Donna M.  Driscoll, PhD

Serpil C. Erzurum, MD

Chair, Lerner Research Institute

Thomas A. Hamilton, PhD

Vice Chair, Lerner Research Institute

Donna M. Driscoll, PhD

Director, Faculty Center

Christine Moravec, PhD
Charlotte Bhasin, MOT, OTR/L
James D. Ellis, JD, MBA

Christine Moravec, PhD

Director, Research Education and Training Center

Charlotte Bhasin, MOT, OTR/L

Executive Director, Health and Patient-Focused Research

James D. Ellis, JD, MBA

Executive Director, Strategic Alliances and Technology Development

Heather Huston Barkley, MBA
Mary Ann Verbic, MT (ASCP) SI
Shannon Barnes, MS

Heather Huston Barkley, MBA

Executive Director of Development

Mary Ann Verbic, MT (ASCP) SI

Executive Director, Exploratory Biomedical Sciences

Shannon Barnes, MS

Communications Director